SingletO2 Therapeutics has developed a patented device to safely, rapidly and effectively treat gum disease (periodontitis). The tip of the device's optical fiber, inserted into the periodontal pocket, painlessly kills the bacteria that cause periodontitis without using antibiotics. This game-changing technology is safer and more effective than current treatments.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Vetted Programs/Awards: NIH SBIR Phase II, NIH STTR Phase I, NSF STTR Phase I
Organization Type: Early-stage Startup (Seed)
Showcase Booth: 526T
Market Keywords: dentistry, periodontics, antimicrobial photodynamic therapy